WEST PHARMACEUTICAL SERVICESWST
ASignal's systematic analysis rates WST as Neutral.
Reflects the latest available analysis · analyzed Oct 14, 2026
The case on WST
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong financial health with debt-to-equity ratio of 0.11x
- Healthy free cash flow of $277.94M supporting operations and returns
- Solid operating margin at 22.47%
- ROE of 19.09% indicating efficient capital use
- Current price near middle Bollinger Band with neutral RSI at 52.15
- Positive price momentum of 3.05%
- Overvalued on P/E (48.16x) and forward P/E (37.68x) relative to growth
- High PEG ratio of 2.90x suggests premium valuation
- Price-to-sales at 7.96x above sector median
- MACD below signal line with negative histogram, indicating weakening momentum
- Lack of Reddit sentiment data limits retail demand visibility
Peers
Clustered with WST by analysis-profile similarity.
See the full verdict on WST
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes WST
Most investors never get a second opinion, let alone several. ASignal runs WST past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.